Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne W Bell

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Science (New York, N.Y.)|January 6, 2007
An X chromosome gene, WTX, is commonly inactivated in Wilms tumorMiguel N Rivera, Woo Jae Kim, Julie Wells, et al.
The New England Journal of Medicine|May 1, 2004
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibThomas J Lynch, Daphne W Bell, Raffaella Sordella, et al.
The Journal of Biological Chemistry|March 12, 2010
A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathwayMyoung Shin Kim, Seung Kew Yoon, Frank Bollig, et al.
BMC Cancer|November 28, 2014
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1Meghan L Rudd, Hassan Mohamed, Jessica C Price, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Cancer Research|April 6, 2006
Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesisGromoslaw A Smolen, Beth Muir, Gayatry Mohapatra, et al.
Oncotarget|November 16, 2017
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trialsHelen J MacKay, Douglas A Levine, Victoria L Bae-Jump, et al.
Nature Genetics|October 30, 2012
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genesMatthieu Le Gallo, Andrea J O'Hara, Meghan L Rudd, et al.
The New England Journal of Medicine|July 4, 2008
Detection of mutations in EGFR in circulating lung-cancer cellsShyamala Maheswaran, Lecia V Sequist, Sunitha Nagrath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Science (New York, N.Y.)|January 6, 2007
An X chromosome gene, WTX, is commonly inactivated in Wilms tumorMiguel N Rivera, Woo Jae Kim, Julie Wells, et al.
The New England Journal of Medicine|May 1, 2004
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibThomas J Lynch, Daphne W Bell, Raffaella Sordella, et al.
The Journal of Biological Chemistry|March 12, 2010
A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathwayMyoung Shin Kim, Seung Kew Yoon, Frank Bollig, et al.
BMC Cancer|November 28, 2014
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1Meghan L Rudd, Hassan Mohamed, Jessica C Price, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinibDavid M Jackman, Beow Y Yeap, Lecia V Sequist, et al.
Cancer Research|April 6, 2006
Frequent met oncogene amplification in a Brca1/Trp53 mouse model of mammary tumorigenesisGromoslaw A Smolen, Beth Muir, Gayatry Mohapatra, et al.
Oncotarget|November 16, 2017
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trialsHelen J MacKay, Douglas A Levine, Victoria L Bae-Jump, et al.
Nature Genetics|October 30, 2012
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genesMatthieu Le Gallo, Andrea J O'Hara, Meghan L Rudd, et al.
The New England Journal of Medicine|July 4, 2008
Detection of mutations in EGFR in circulating lung-cancer cellsShyamala Maheswaran, Lecia V Sequist, Sunitha Nagrath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Epidermal growth factor receptor mutation testing in the care of lung cancer patientsLecia V Sequist, Victoria A Joshi, Pasi A Jänne, et al.
Pageof 7